HAT-2

N/A

Report date: 2023/03/12 17:11:11

NME

Base Information

Drug NameHAT-2

Drug Alias NameHAT-2

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistone deacetylase 2 inhibitors

TargetsHistone deacetylase 2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEpizyme Inc

China Registration ClassN/A

Active CompaniesEpizyme Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A